NYC Mayor Eric Adams Files Lawsuit Against 11 E-cigarette Retailers

Regulations by 2FIRSTS.ai
Apr.07.2024
NYC Mayor Eric Adams Files Lawsuit Against 11 E-cigarette Retailers
NYC Mayor Eric Adams announced legal action against 11 e-cigarette distributors for selling flavored disposable e-cigarettes popular among teens.

According to a report from New York City media on April 4th, Mayor Eric Adams announced that the city has filed lawsuits against 11 e-cigarette distributors, accusing them of engaging in illegal sales of flavored disposable e-cigarettes. The 11 defendants are spread across Brooklyn, Queens, Long Island, and the upper regions of New York State, and are accused of selling and providing flavors such as strawberry, mint, and blueberry that are highly popular among teenagers.

 

The lawsuit aims to prevent further sales of these illegal products and seeks damages and fines in accordance with state and city laws. This lawsuit is a complement to the federal lawsuit that the city government is planning to file in 2023, in which two defendants have already been barred by the court from selling and transporting flavored e-cigarettes in the city.

 

The 11 accused e-cigarette distributors include: EnvironMD Group LLC, GT Imports, Kayla Wholesale, Inc. (The Vapery), KLCC Wholesale Inc., V. Trading, LLC, Pioneer Distribution, Inc. (Wevapeusa.com, Supreme LLC), RZ Smoke Inc., Star Zone Inc., Urban Smoke Distributors, Vape More Inc. and More LLC, and Vape Plus Distribution Corp. (G&A Distribution).

 

Mayor Adams stated that he will enforce strict measures to combat the illegal sale of e-cigarettes. In January 2020, the FDA banned the sale of flavored e-cigarette products unless companies can prove that the benefits of the product outweigh its potential harm, but so far, no flavored e-cigarette company has met this standard. Additionally, New York City implemented a comprehensive ban on possessing and selling flavored e-cigarettes in 2020, both in retail stores and online. Furthermore, New York State and many other cities also prohibit the retail sale of flavored e-cigarettes. The federal Prevent All Cigarette Trafficking Act also prohibits any e-cigarette sales other than in-person sales, unless the sale complies with all state and local laws in the jurisdiction where the sale occurs. According to the New York City Administrative Code, selling flavored disposable e-cigarettes is impossible.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G subsidiary Taeya Industry booked heavy impairment losses after overinvesting in capacity based on inaccurate demand forecasts. Although KT&G aims to offset the damage through global value-chain expansion, Taeya’s financial health remains severely strained, and the company is now devising new export programs to utilize its idle facilities.
Jul.15 by 2FIRSTS.ai
Product | Another Brand Joins the “Fog-Free” Trend: Hyperbar Launches ZeroFog Twin 50K
Product | Another Brand Joins the “Fog-Free” Trend: Hyperbar Launches ZeroFog Twin 50K
E-cigarette brand Hyperbar recently unveiled its “ZeroFog Twin 50K” on official social media. The device features a dual-tank design (13ml + 9ml) and claims up to 50,000 puffs. Its key feature is a one-click switch between regular and fog-free modes. The product was previously showcased at the Dubai Vape Expo.
Jul.21 by 2FIRSTS.ai
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
The FDA has launched the Commissioner’s National Priority Voucher (CNPV) program, reducing the review time for certain drugs to as little as 1–2 months. While the program currently applies only to pharmaceuticals, it demonstrates the FDA’s capacity to reform its review pathways. Whether a similar mechanism could extend to tobacco products now appears to be a matter of timing and technical details.
Jun.18
Reuters: Tariffs and Crackdowns Drive Sharp Decline in U.S. Supply of Chinese E-Cigarettes like Geek Bar
Reuters: Tariffs and Crackdowns Drive Sharp Decline in U.S. Supply of Chinese E-Cigarettes like Geek Bar
Reuters reports that U.S. imports of Chinese e-cigarettes have fallen sharply due to high tariffs and stricter FDA crackdowns. Brands like Geek Bar face major supply shortages and rising prices, though demand remains strong. Some Chinese makers are moving production to Southeast Asia to avoid regulatory pressure.
Jun.09 by 2FIRSTS.ai